* Labcorp Holdings Inc LH.N reported quarterly adjusted
earnings
of $3.45 per share for the quarter ended December 31, higher
than the same quarter last year, when the company reported EPS
of $3.30. The mean expectation of seventeen analysts for the
quarter was for earnings of $3.39 per share. Wall Street
expected results to range from $3.26 to $3.48 per share.
* Revenue rose 9.8% to $3.33 billion from a year ago;
analysts
expected $3.31 billion.
* Labcorp Holdings Inc's reported EPS for the quarter was
$1.70.
* The company reported quarterly net income of $143.4
million.
* Labcorp Holdings Inc shares had risen by 9.0% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"
Wall Street's median 12-month price target for Labcorp Holdings
Inc is $270.00
This summary was machine generated from LSEG data February 6 at
02:32 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 3.39 3.45 Beat
Sep. 30 2024 3.48 3.50 Beat
Jun. 30 2024 3.78 3.94 Beat
Mar. 31 2024 3.48 3.68 Beat